Tuesday, 10 August 2021

Demetra to partner with Astorg

Well, whatever. I mean ... I don't know. 'If it makes them happy, boss ...' Yeah, yeah. What do we care? I suppose there's no harm in it.

[Are they happy?]

Anyway ...

Milan, 6th August 2021 - Demetra Holding S.p.A. ("Demetra") is pleased to announce that it has signed a partnership with Astorg, a leading global private equity firm, to support the next development phase of the Group. Astorg will support the Company in its future growth plans, continuing to invest in innovation and product quality both organically and inorganically. At the same time, the minority shareholder Keensight Capital will exit.

Organically and inorganically?! Isn't that a bit over the top? 'They know what they're doing.' Ha! I hope so, Voice, I really do.

Created in 2016 following the combination of Italy-based Tecres and Germany-based Osartis, Demetra develops, manufactures, and distributes products used in orthopaedic implant surgeries and spine interventions.

Oh, I'm getting shivers ... ah, just thinking about it. 'Where?' What? 'Where are you getting the shivers, boss?' Where do you think?

Idiot!

More specifically, the Company is one of the leading suppliers of bone cement, a product used for the fixation of orthopaedic implants and for the filling of vertebral compression fractures. Demetra has also pioneered the preformed spacer technology: these medical devices are ready-to-use, antibiotic-loaded temporary implants used to treat local infections that can occur to patients who have had implant surgery. Demetra's preformed spacers are the industry standard and allow to better treat infections, to reduce surgery time and to improve patient mobility compared to previous generation products.

Yeah, yeah. This is too much information. Christ. / Let's hear what Denis has got to say for himself ...

[The Preformed Spacers? Weren't they a band in the late Sixties?]

Denis Faccioli, CEO at Demetra, says: "We would like to thank the Astorg team for the enthusiasm they have demonstrated for our business. Astorg will support our ambitious growth plan, and together we will continue this outstanding entrepreneurial adventure. Demetra's success is the result of a team effort that has allowed us to offer innovative solutions to our clients that have placed their trust in us for many years."

Oh, all right. / Lorenzo? Come on, son!

Lorenzo Zamboni, Partner at Astorg, says: "We have tracked Demetra for many years and have been impressed with its strong market position, innovative products and consistent strong positive feedback from customers. We are excited to be part of a Company whose mission statement is to improve patient lives and we are thrilled to partner with Denis Faccioli and Massimo Grazioli and their team to help shape the future of this unique Group. We will do our utmost to help the management team accelerate international growth, to pursue the development of new products and new applications and to unlock M&A opportunities."

Well, okay, Lorenzo, it's your life. 'You're not going to tell him how to live it.' I would never do that, Voice.

ENDS

...

Anything else?

I had a musical dream last night. For some strange reason I was playing the piano. (I haven't done that for thirty years.) It was a lovely original tune. A bit classical. But get this! I dreamt that I woke up and was trying to hum the melody into my Zoom Handy thing. Then I dreamt I was trying to find the recording on the machine, but it wasn't there. Eventually, I really woke up ... with no tune, no recording, nothing!

Never mind, eh?

...

Anything more else?

I'm trying to stay "active" between half five in the morning and half nine at night now, seven days a week. That means blogging, playing the guitar, writing songs, going for walks, listening to the Lennon audiobook. It doesn't mean watching TV, watching YouTube videos, or ... any sort of goofing off, you dig?

If the sun starts shining ... I might go out for a walk after lunch. After dinner tonight, I'm going to finish Mighty Soul - if I can.

Laters.